Delivery Order SPE2DB25D3404-SPE2DB25FUNJB

Award Date 5/8/25
Potential Completion Date 5/9/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,180.98, is for the delivery of GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a medication commonly used to treat certain medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,668.39 firm fixed-price delivery order is for the supply of Glycopyrrolate 0.2 mg/ml vial, 2 ml, with a performance period ending on May 14, 2025. The award is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,845.60 firm-fixed-price delivery order is for the supply of glycopyrrolate 1 mg/5 ml vials, a medication used to treat certain conditions. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564246806 - GLYCOPYRROLATE 0.2 MG/ML VIAL 20ML. The contract has a ceiling value of $2,349.10 and a completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of...
This is a federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,476.75 delivery order contract is for the supply of GLYCOPYRROLATE 4 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has an ultimate completion date of October 26, 2023 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a medical product, with a ceiling value of $7,484.43 and a period of performance through May 30, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. This award is associated with a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,157.14 firm fixed-price delivery order is for the supply of 4 mg/20 ml vials of the medication glycopyrrolate. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies supporting...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 mg/20 ml vials of glycopyrrolate, a medication used for various medical conditions. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $11,511.25 and a completion date of November 3, 2023. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,713.94 fixed-price delivery order is for the supply of 4565056143 GLYCOPYRROLATE 1 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,764.01, is for the supply of the medication glycopyrrolate 1 mg/5 ml vial 5 ml. The contract is a firm fixed-price delivery order with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUNJB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,109.89 firm fixed-price delivery order is for the supply of GLYCOPYRROLATE 0.2 MG/ML VIALML, a medication. The contract has an ultimate completion date of May 9, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds this prime contract, enabling it to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/10/25, 1:07 AM